Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same

---
identifier: "/us/fr/01-27864"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same"
title_number: 0
title_name: "Federal Register"
section_number: "01-27864"
section_name: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same"
positive_law: false
currency: "2001-11-06"
last_updated: "2001-11-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "01-27864"
document_type: "notice"
publication_date: "2001-11-06"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "66 FR 56088"
fr_volume: 66
fr_action: "Notice."
---


#  Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same

**AGENCY:**

Army Medical Research and Materiel Command, DOD.

**ACTION:**

Notice.

**SUMMARY:**

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application No. 09/692,938 entitled “Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same” and filed October 20, 2000. Foreign rights are also available (PCT/US00/29278). The United States Government, as represented by the Secretary of the Army, has rights in this invention.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. Both at telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

A neuroprotectant composition wherein the active ingredient is pGLU-GLU-PRO-NH2 or a combination of pGLU_GLU-PRO-NH2 (EEP) and N-tert-Butyl-α-(2sulfophenyl)nitrone (SPBN) or other nitrone. A method of treating and preventing diseases and injuries of the brain, spinal cord and retina is also presented by administering the endogenous tripeptide EEP to a subject as a neuroprotectant or by administering EEP in combination with SPBN or other nitrone.

Luz D. Ortiz,

Army Federal Register Liaison Officer.